Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Jeffrey Graham ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Genetic Discrimination And Canadian Law
However, in light of recent events, it appears likely that Canada will in fact join the nations that have enacted legislative action to address genetic discrimination.
Canada
6 Jun 2016
2
The 2012 Rx&D Code Of Ethical Practices
Effective March 31, 2012, the members of Canada’s Research-Based Pharmaceutical Companies ("Rx&D") will be subject to a new Code of Ethical Practices (the "New Code").
Canada
13 Feb 2012
3
Government Of Ontario Ban On Private Label Generics Is Upheld By Court Of Appeal
2012The complex market and regulatory framework for the sale of drugs in Ontario has been clarified, to some extent, by the recent decision of the Ontario Court of Appeal.
Canada
11 Jan 2012
4
BC Pharmaceutical Policy Reforms
Following the lead of Ontario (See, BLG Life Sciences Advisory - 2010 Ontario Drug System Reforms), British Columbia has taken steps to further reform its provincial policy with respect to pharmaceuticals.
Canada
20 Jul 2010
5
2010 Ontario Drug System Reforms
Effective July 1, 2010 important changes to the rules governing the sale of drugs in Ontario will come into force.
Canada
 
25 Jun 2010
6
2010 Ontario Drug System Reforms
The Government of Ontario has released its proposals for changes to the drug system in Ontario, following a public consultation process that began in June 2009.
Canada
 
20 Apr 2010
7
Implementation Of Changes To "Competition Act" - Implications For Biotech And Pharma Sector
There are some important changes to the Competition Act (the "Act") that came into effect on March 12, 2010, that are of particular interest to the biopharmaceutical sector. These changes are briefly summarized below, along with a discussion of practical consequences.
Canada
16 Mar 2010
Links to Result pages
 
1